,,ii #aafth ,,congress #ast ,session ,s4 #bagh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,july #ah1 #bjai,mr4 ,rubio 7for himself and ,mr4 ,cornyn7 introduced the following bill2 which was read twice and referred to the ,committee on the ,judiciary ,a ,,bill ,to impose requirements in certain actions for patent infringement1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,prevent ,abuse of the ,legal ,system ,act or the ,,pals ,act4 #b4 ,covered infringement actions 7a7 ,definitions ,in this section-- 7#a7 the term affected proceeding means an action for infringement of a patent under title #ce1 ,united ,states ,code1 an investigation under section #ccg of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #accg71 or any other administrative or judicial proceeding in which-- 7,a7 a patent issued by the ,united ,states ,patent and ,trademark ,office is a subject of the proceeding2 and 7,b7 a designated entity-- 7i7 is the owner or exclusive licensee of the patent described in subparagraph 7,a72 7ii7 has a financial interest in the outcome of the proceeding2 or 7iii7 has direct or indirect control over the conduct of the litigation of the matter by the holder of the patent described in subparagraph 7,a72 7#b7 the term covered regulations means the ,export ,administration ,regulations under subchapter ,c of chapter ,,vii of title #ae1 ,code of ,federal ,regulations2 and 7#c7 the term designated entity means-- 7,a7 an entity on the entity list maintained by the ,bureau of ,industry and ,security of the ,department of ,commerce and set forth in ,supplement ,no4 #d to part #gdd of title #ae1 ,code of ,federal ,regulations2 or 7,b7 any parent1 subsidiary1 or affiliate of an entity described in subparagraph 7,a74 7b7 ,conduct of affected proceedings ,notwithstanding any other provision of law or regulation1 the following requirements shall apply with respect to an affected proceeding3 7#a7 ,the pleadings alleging infringement of the patent shall1 with respect to each patent in which a designated entity has an interest-- 7,a7 state with particularity the facts and circumstances constituting that infringement1 including-- 7i7 all patent claims alleged to be infringed2 and 7ii7 all products and services alleged to be infringed2 7,b7 provide a detailed identification of the specific elements of each patent claim that is found in each product and service identified under subparagraph 7,a77ii72 and 7,c7 state with particularity all damages or other remedies sought in the proceeding4 7#b7 ,excluding legal counsel for the designated entity involved1 neither the designated entity nor the agents or representatives of the designated entity may obtain through discovery1 or by other means1 any non-public information of any entity or person related to any technical features or operation of a product or service4 7#c7 ,upon the filing of the affected proceeding1 the designated entity involved shall provide notice of the proceeding to the ,department of ,justice and the ,united ,states ,patent and ,trademark ,office4 7#d7 ,the ,united ,states shall have the unconditional right to intervene as a party in the proceeding under rule #bd7;a7 of the ,federal ,rules of ,civil ,procedure4 7c7 ,restrictions on certain patent transactions ,notwithstanding any other provision of law or regulation1 the following requirements shall apply with respect to the sale or exclusive license of a patent issued by the ,united ,states ,patent and ,trademark ,office3 7#a7 ,the sale or license is prohibited if the sale or license is to a designated entity and the entity has not undergone review under section #gba of the ,defense ,production ,act of #aiej 7#ej ,u4,s4,c4 #defe74 7#b7 ,the sale or license is prohibited if the sale or license is to or by a designated entity and the manufacture1 sale1 use1 import1 or export of a product or service that is subject to the covered regulations would infringe the patent1 unless an appropriate license is granted under the covered regulations4 7#c7 ,with respect to a patent not involving a drug or biological product1 the sale or license of the patent to or by a designated entity to any foreign entity or affiliate shall require notification pursuant to rules under subsection 7d77#a71 and the waiting period described in subsection 7b77#a71 of section #g;,a of the ,clayton ,act 7#ae ,u4,s4,c4 #ah;a71 notwithstanding any other provision of that ,act4 7d7 ,list ,the ,under ,secretary of ,commerce for ,intellectual ,property and ,director of the ,united ,states ,patent and ,trademark ,office shall maintain a publicly available list of all designated entities4